Learn about UCSF’s response to the coronavirus outbreak, important updates on campus safety precautions, and the latest policies and guidance on our COVID-19 resource website. You can also access information from the CDC. Learn more
UCSF's Class of 2020 has a lot to celebrate. After years of hard work, sacrifice, and dedication to the mission of advancing health worldwide, nearly 1,000 graduates have earned their degrees this year.
As cases of COVID-19 continue to mount in Navajo Nation, UC San Francisco is sending a second team of health care workers — 13 nurses and six physicians — to Arizona to help provide urgently needed support to the largest hospitals serving Navajo patients.
For the UCSF class of 2020, the usual joy and excitement of graduation is mixed with unusual uncertainty. As we celebrate the #UCSFgrads of 2020, we asked them to share how they’re feeling at this moment, in their own words.
Amid so little good news, early clinical trial results for the anti-viral drug remdesivir have offered hope. The drug appeared to help patients recover faster, from 15 days to 11 days. But the newest obstacle may be the uncertainty that surrounds how the drug will be distributed to patients.
A product containing healthy vaginal bacteria has proved effective against recurrent bacterial vaginosis (BV), an extremely common vaginal infection that is associated with preterm birth, HIV infection and problems with in vitro fertilization.
The testing was conducted by Unidos En Salud, a unique partnership between Mission community organizers in the Latino Task Force for COVID-19, UCSF researchers, the City and County of San Francisco, and the San Francisco Department of Public Health.